Biochemical Mechanisms of Cerebral Vasospasm

脑血管痉挛的生化机制

基本信息

  • 批准号:
    6894799
  • 负责人:
  • 金额:
    $ 32.81万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2003
  • 资助国家:
    美国
  • 起止时间:
    2003-06-01 至 2007-05-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Vasospasm is a frequent cause of delayed ischemic stroke in subarachnoid hemorrhage (SAH) patients. In this project we will evaluate the molecule(s) that are responsible for causing SAH-induced cerebral vasospasm. The cause of the vasospasm is largely unknown but it has been suggested to be due to a vasoactive molecule in the hemorrhagic CSF. We have found that bilirubin oxidation products (BOXes) are found in the CSF of SAH patients and propose that the BOXes are phosphatase inhibitors that can cause cerebral vasospasm. There have been three structurally related molecules identified. These molecules produce prolonged contractile effects on the vessels in vivo and in vitro that are strikingly similar to the prolonged vasospasm seen from the CSF of SAH patients with vasospasm. We suggest that smooth muscle protein phosphatase inhibition causes prolonged vasospasm. Moreover it is the BOXes that are the phosphatase inhibitors that produce prolonged vasospasm in patients following subarachnoid hemorrhage. In Aims #1 and #2 using cranial window technique, we will examine the time course of cerebral vasospasm in rats caused by the BOXes, and will assess the potency of the individual BOXes. The degree of vascular constriction will be studied over 14 days and the brain examined for evidence of damage. In Aim #3 we will show that BOXes inhibit phosphatases and that this leads to vasospasm using porcine basilar artery in vitro. The long-term goal for this project is to define the molecular causes of vasospasm (such as bilirubin oxidation products, phosphatase inhibition) in order to develop effective diagnostic, therapeutic and preventative approaches for this cerebral vascular disease.
描述(由申请人提供):血管痉挛是蛛网膜下腔出血(SAH)患者迟发性缺血性卒中的常见原因。在这个项目中,我们将评估导致sah诱导的脑血管痉挛的分子。血管痉挛的原因尚不清楚,但据推测可能与出血性脑脊液中的血管活性分子有关。我们发现胆红素氧化产物(box)存在于SAH患者的脑脊液中,并提出box是引起脑血管痉挛的磷酸酶抑制剂。已经鉴定出三种结构相关的分子。这些分子在体内和体外对血管产生延长的收缩作用,这与SAH患者伴血管痉挛的脑脊液中观察到的延长的血管痉挛惊人地相似。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

JOSEPH Floyd CLARK其他文献

JOSEPH Floyd CLARK的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('JOSEPH Floyd CLARK', 18)}}的其他基金

Bilirubin oxidation and intracerebral hemorrhage
胆红素氧化与脑出血
  • 批准号:
    7092514
  • 财政年份:
    2005
  • 资助金额:
    $ 32.81万
  • 项目类别:
Bilirubin oxidation and intracerebral hemorrhage
胆红素氧化与脑出血
  • 批准号:
    7235306
  • 财政年份:
    2005
  • 资助金额:
    $ 32.81万
  • 项目类别:
Bilirubin oxidation and intracerebral hemorrhage
胆红素氧化与脑出血
  • 批准号:
    7163681
  • 财政年份:
    2005
  • 资助金额:
    $ 32.81万
  • 项目类别:
Bilirubin oxidation and intracerebral hemorrhage
胆红素氧化与脑出血
  • 批准号:
    6979926
  • 财政年份:
    2005
  • 资助金额:
    $ 32.81万
  • 项目类别:
Bilirubin oxidation and intracerebral hemorrhage
胆红素氧化与脑出血
  • 批准号:
    7432522
  • 财政年份:
    2005
  • 资助金额:
    $ 32.81万
  • 项目类别:
Bilirubin oxidation and intracerebral hemorrhage
胆红素氧化与脑出血
  • 批准号:
    7616227
  • 财政年份:
    2005
  • 资助金额:
    $ 32.81万
  • 项目类别:
Creatine Transport Across the Blood Brain Barrier
肌酸跨血脑屏障转运
  • 批准号:
    6917307
  • 财政年份:
    2004
  • 资助金额:
    $ 32.81万
  • 项目类别:
Creatine Transport Across the Blood Brain Barrier
肌酸跨血脑屏障转运
  • 批准号:
    6812240
  • 财政年份:
    2004
  • 资助金额:
    $ 32.81万
  • 项目类别:
Creatine Transport Across the Blood Brain Barrier
肌酸跨血脑屏障转运
  • 批准号:
    7062430
  • 财政年份:
    2004
  • 资助金额:
    $ 32.81万
  • 项目类别:
Biochemical Mechanisms of Cerebral Vasospasm
脑血管痉挛的生化机制
  • 批准号:
    6792368
  • 财政年份:
    2003
  • 资助金额:
    $ 32.81万
  • 项目类别:

相似海外基金

Bilirubin Catabolism induces Plasminogen-Activator Inhibitor 1 (PAI-1) worsening Metabolic Dysfunction
胆红素分解代谢诱导纤溶酶原激活剂抑制剂 1 (PAI-1) 恶化代谢功能障碍
  • 批准号:
    10750132
  • 财政年份:
    2024
  • 资助金额:
    $ 32.81万
  • 项目类别:
Severe neonatal hyperbilirubinemia (SNH) and the expression of UDP-glucuronosyltransferase 1A1 (UGT1A1) play key roles in the development of necrotizing enterocolitis (NEC)
严重新生儿高胆红素血症 (SNH) 和 UDP-葡萄糖醛酸基转移酶 1A1 (UGT1A1) 的表达在坏死性小肠结肠炎 (NEC) 的发生中起关键作用
  • 批准号:
    10713549
  • 财政年份:
    2023
  • 资助金额:
    $ 32.81万
  • 项目类别:
Determining the Influence of Clinicodemographic, Biologic and SDOH Factors in Racial and Ethnic Disparities in the Prognosis of Alcohol-Associated Liver Disease
确定临床人口统计学、生物和 SDOH 因素对酒精相关性肝病预后中种族和民族差异的影响
  • 批准号:
    10785492
  • 财政年份:
    2023
  • 资助金额:
    $ 32.81万
  • 项目类别:
Mechanism of neutrophilic NCF1 in alcohol-associated liver disease pathogenesis
中性粒细胞NCF1在酒精相关性肝病发病机制中的作用机制
  • 批准号:
    10723321
  • 财政年份:
    2023
  • 资助金额:
    $ 32.81万
  • 项目类别:
Heme-, Redox-, and CO-dependent Regulation of Heme Homeostasis
血红素稳态的血红素、氧化还原和CO依赖性调节
  • 批准号:
    10660290
  • 财政年份:
    2023
  • 资助金额:
    $ 32.81万
  • 项目类别:
Immune-Metabolic Regulation of Biliary Atresia
胆道闭锁的免疫代谢调节
  • 批准号:
    10645435
  • 财政年份:
    2023
  • 资助金额:
    $ 32.81万
  • 项目类别:
The study for protection from neonatal bilirubin encephalopathy using humanized UGT1A mice
使用人源化 UGT1A 小鼠预防新生儿胆红素脑病的研究
  • 批准号:
    23K07288
  • 财政年份:
    2023
  • 资助金额:
    $ 32.81万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Mitochondrial Dysfunction underlies treatment related hepatotoxicity in Hispanics with acute lymphoblastic leukemia
线粒体功能障碍是西班牙裔急性淋巴细胞白血病治疗相关肝毒性的基础
  • 批准号:
    10675403
  • 财政年份:
    2023
  • 资助金额:
    $ 32.81万
  • 项目类别:
A point of care-device for the determination of creatinine phosphokinase (CPK), the CPK Now
用于测定肌酸酐磷酸激酶 (CPK) 的护理点设备,CPK Now
  • 批准号:
    10822139
  • 财政年份:
    2023
  • 资助金额:
    $ 32.81万
  • 项目类别:
Identification of Early Metabolomic and Immune Endotypes of Allergy and Asthma: An Integrated Multiomics Approach
过敏和哮喘早期代谢组学和免疫内型的鉴定:综合多组学方法
  • 批准号:
    10896779
  • 财政年份:
    2023
  • 资助金额:
    $ 32.81万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了